Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Global | Publication | November 2015
Norton Rose Fulbright’s global blockchain and cryptocurrency team has produced a global legal and regulatory guide to cryptocurrencies.
The guide is issued in a series of chapters, published monthly.
To date, most litigation involving cryptocurrency has related to breach of contract and fraud (the Butterfly Labs case) or insolvency (Mt Gox). However, as cryptocurrencies become more widely used it is reasonable to expect that the litigation risk surrounding them will also increase.
A common narrative in the cryptocurrency space is that the public ledger and cryptocurrency units are somehow beyond the reach of the state and the courts. This is partly because, from a practical point of view, decentralised peer-to-peer networks are governed and operated on the principle of distributed consensus and are designed to frustrate the possibility of third-party interference – including that of the courts. This narrative is misleading. In many cases, courts will be able to exert control over individuals in their jurisdiction to compel the disclosure of private keys and thereby access cryptocurrency. That process is a common thread which we will explore in this chapter.
In this chapter we will consider:
If you would like to discuss any aspect of this topic further, please get in touch.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
While country risk cannot be avoided in cross-border transactions entirely, it can be effectively mitigated through careful transaction structuring and tailored contractual protections.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023